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ABSTRACT
Background:  Prevalence of  pulmonary
tuberculosis is very high in India. Lung cancer
is the most common cancer in males in Delhi
and because of close similarity in clinical and
radiological features of lung cancer and
tuberculosis  many of lung cancer patients
have had received empirical  anti tubercular
treatment (ATT) before a diagnosis of  lung
cancer was established. True incidence of
pulmonary tuberculosis in lung cancer is not
known. Tuberculosis in lung cancer may get
reactivated following chemotherapy and/or
radiation therapy. Simultaneous presentation
of tuberculosis and lung cancer independent
of treatment with immunosuppresants,
however, is rare.
Material and Methods: At our center we
evaluated records of 580 lung cancer patients
seen over a period of  5 years to see incidence
of  pulmonary tuberculosis in lung cancer.
Patients who had been worked up for
pulmonary tuberculosis like sputum or
bronchoalveolar lavage (BAL) for AFB smear
or culture were identified.
Results: Two hundred and ninety eight of
these patients were worked up for pulmonary
tuberculosis. Twelve patients in the present
study had  documented evidence of
simultaneous existence of pulmonary
tuberculosis (acid fast bacilli positive  sputum
and or culture positivity) and lung cancer.
Radiologically, no separate active tubercular
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lesion was identified except in one patient who
had left upper zone fibro parenchymal lesion.
Fibrosis and calcification on chest X-rays
(CXR) suggestive of old tuberculosis were
evident in 7 patients.  Eight patients died of
progressive lung cancer within 3 months of
diagnosis, 4 patients became  acid fast bacilli
(AFB) negative after 2 months of anti
tubercular therapy. Diagnosis of  lung cancer
was delayed in 4 patients as they were
receiving anti tubercular therapy after
detection of AFB in sputum.
Conclusion: Recognition of tuberculosis is
important not only because it is curable but
also due to the fact that its presence interferes
with radiological assessment to chemotherapy
and radiotherapy. Sputum acid fast smear may
be done more frequently  in patients of  lung
cancer in countries where tuberculosis has
high prevalence. The true incidence may be
still higher and newer techniques e.g. PCR
based and others may help in knowing true
incidence of co existence of lung cancer and
pulmonary tuberculosis.
INTRODUCTION
Lung cancer is the most common cancer in males
in Delhi.1 Pulmonary tuberculosis may occur
before, during or late in the course of  lung cancer.2,9
Local and systemic  effects of tumour as well as the
immunosuppression induced by anticancer
treatment predisposes the patients of lung cancer
to opportunistic infections including tuberculosis.
However, true incidence of  pulmonary
tuberculosis in lung cancer is not known.
Prevalence of tuberculosis in India as judged by
standard PPD tuberculin test is 60-80%.10  In
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majority of patients tubercular infection remains
dormant; and clinically apparent tuberculosis
develops in approximately 10% of infected
patients soon after primary infection or years later
due to reactivation.
In most reported cases tuberculosis
developed following treatment with chemotherapy
and/or radiation therapy in lung cancer
patients.9,11  Gettler et al12 reported  a case of
simultaneous presentation of Mycobacterium
Kansasii infection and small cell lung cancer
illustrating reactivation of latent infection
independent of either chemotherapy and radiation
therapy.  Author claimed it to be the first
documented case of simultaneous mycobacterial
infection and primary lung cancer independent of
immunosuppressive therapy.
At our center we evaluated records of 580
lung cancer patients seen over a period of  5 years
to see the incidence of pulmonary tuberculosis in
lung cancer.
MATERIAL AND METHODS
Case records of all the lung cancer patients seen
from January 1991  to  December 1995 in Medical
Oncology department were analyzed to look for
documented evidence of pulmonary tuberculosis.
Five hundred and eighty cases with diagnosis of
lung cancer were registered during this period.
Two hundred and ninety eight of these patients
were also worked up for pulmonary tuberculosis
either at our institute ( 174) or outside ( 124) with
reports available for review. The work up included
any or combination of; sputum AFB, sputum
culture, examination of BAL fluid, and ESR
examination.
The cases were subjected for these tests if
they had either of the followings-
(i) Past or family history of tuberculosis and or
productive cough (ii) Fever (iii) Hemoptysis (iv)
Strong clinical suspicion, or (v) As per practice if
bronchoscopy has been done then examination of
BAL
RESULT
Twelve  of these patients had evidence of
pulmonary tuberculosis. Ten had acid fast bacilli
(AFB) positive smear (four had positive culture
also). Two patients who had negative smear were
positive for culture suggesting active tubercular
infection.  None of the patients at the time of
documentation of tubercular bacilli in sputum has
had any chemotherapy or radiation therapy for
their lung cancer.  The clinical profile of  these
patients is being presented.  Important issues
relevant to chemotherapy and radiation therapy for
such coexistence are discussed.
CLINICAL DETAILS
The clinical features of all the 12 patients are
summarized in table  1.
DISCUSSION
The prevalence of tuberculosis in India is about 60-
80%. Majority of  patients have subclinical
infection and about 10% will develop clinically
detected disease. This is in contrast to developed
countries where prevalence rate is 2-3%.
Pulmonary tuberculosis in India is one of the major
public health problem. It has been estimated that
nearly 15 million new cases are diagnosed each
year in India out of  which 90% have pulmonary
tuberculosis. It causes 2 million deaths each year
world over.10
Reactivation of latent tubercular infection in
patients with lung cancer seems to be the cause of
tuberculosis in such patients.  Latent infection of
tuberculosis may be activated by local and
systemic effects of lung tumour or following
chemotherpay and radiation therapy.  Lung cancer
is known for its various hormonal secretions and
cortisol is one of them.  Although reactivation is
proposed as the likely explanation for occurrence
of tuberculosis during the course of lung cancer or
at its inception; a possibility of fresh pulmonary
infection cannot be ruled out.  As regarding the
reason for reactivation no satisfactory explanation
is available.  It is possible that microorganisms
may conceal their true antigen from immune
system but years later, during suboptimal
functioning of immune system reactivation may
occur.13
Many reported coexistence of tuberculosis
and lung cancer following radiation therapy and/
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or chemotherapy. Negata et al9 analyzed the
pattern of  infections in 304 patients who died of
lung cancer.  In 9 patients lung cancer was
complicated with Mycobacterial infection.  In
retrospect fever, new infiltrates on CXR and pleural
effusion were thought to be due to tuberculosis.
Four of these 9 patients had  evidence of pre-
existent tuberculosis in the form of   old scarring
suggesting reactivation of tuberculosis.  Zventina
et al described 4 patients of Mycobacterial
Kansasii infection complicating lung cancer
following chemotherapy or radiation therapy. 11
They reported that structural changes induced by
either the chemotherapy or radiation therapy
predisposes the patient to reactivation of latent
Mycobacterium Kansasii infection.  Tamura et al
reported  series of 25 patients of lung cancer
having pulmonary tuberculosis,  14 of  which  had
concurrent tuberculosis.14
The overall clinical presentation of active
pulmonary tuberculosis with lung cancer is
dominated by manifestations of  lung cancer.  The
radiological finding characteristic of either disease
is not specific enough to differentiate between the
two processes. Because  aggressive tumour
behavior of  lung cancer leads to early death in
many of these patients, tuberculosis may be
overlooked.  In some of these patients tubercular
process is recognized as terminal flaring up of  chest
infection.9
The exact incidence of tuberculosis in lung
cancer is difficult to assess clinically because of
many reasons; sputum acid fast bacilli positivity
is between 31-82% in pulmonary tuberculosis,
radiologically it  is also difficult to  diagnose
tuberculosis  once patient presents with lung
cancer, and   tuberculin test using PPD is not very
useful in this group of patients due to their old age
and immunosuppression.15,16
In the present series of the 12 positive
patients 6 had fever, 4 had hemoptysis, and 2 had
SVC syndrome and dysphagia.  Radiologically 7 of
our patients had evidence of old scarring on X-ray
with or without calcification.  CAT scan in a patient
revealed areas of  breakdown and cavitating lesion
within the mass lesion.  This patient had squamous
cell histology which is known to cavitate.17  All
these patients were started on anti tubercular
drugs.  In 4 patients AFB negative sputum smear
was documented after 2 months of anti tubercular
therapy.  Eight patients died of  progressive lung
cancer within 3 months of diagnosis; their sputum
smear status could not be restudied.  Among the
cases whose sputum was negative for AFB survival
was between 6 - 10 months.  The overall clinical
manifestation,  radiological manifestations and
prognosis in these patients were dominated by
lung cancer.  Impact of  chemotherapy and
radiation therapy could be monitored in only 4
patients, in whom gross residual disease persisted
and tubercular lesion could not be recognized
separately.
Of the 12 patients discussed here, acid fast-
smear was positive in 10 patients and 2 patients
had negative smear but positive culture. All were
typical M tuberculi infection.  Unlike central
America where M Kansasii infection is endemic.
In India M tuberculi is the most likely pathogen.
A considerable delay in the diagnosis of lung
cancer is likely when sputum smear shows
Mycobacteria.  Failure of anti tubercular drugs to
resolve the lesion radiologically leads to further
investigations in these subset of  patients.  In 4 of
these  patients diagnosis of lung cancer was
considered only after failure of 2-3 months of anti
tubercular drugs.
With chemotherapy  now having an impact
on survival of small cell carcinoma and non small
cell lung cancers; in those cases where tuberculosis
and lung cancer coexist, we are likely to see
tubercular residual lesions mimicking residual
lung tumour. 18  The assumption that this lesion is
a metastatic or recurrent neoplasm should not be
made unless other diseases including tuberculosis
are ruled out before institution/ continuation of
anticancer chemotherapy.
The impact of radiation therapy to such
lesions where tubercular bacteria and lung cancer
coexist is interesting.  Radiation therapy probably
is not lethal to Mycobacteria.  On the contrary, the
resultant necrosis and local effects of tumour
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provide a fertile culture medium for growth of
these organisms.11
Up to 50% of Mycobacteriosis in lung cancer
could be due to atypical Mycobacteria.3,8
Differentiation of Mycobacterial tuberculosis from
atypical Mycobacterial infection is of crucial
importance as atypical Mycobacteriosis is known
to be resistant to anti tubercular drugs and may
require alternate therapy and /or surgery. 6
Pattern and course of  coexistence of
pulmonary tuberculosis and lung cancer in India
may be variable and is presented in table-II.
TABLE-II
CLINICAL COURSE OF COEXISTING TUBERCULOSIS AND LUNG CANCER:
1. Rapidly progressive lung cancer; Tuberculosis masked by lung cancer and remain unrecognized.
2. High prevalence of tuberculosis in India and positive acid fast sputum smear may delay the diagnosis
of  lung cancer.
3. Tuberculosis unrecognized; during therapy with chemotherapy and /or radiation therapy patient
develops fever, pleural effusion or cavitary lesion.8,9 Of  note; up to 2-16% of  squamous cell carcinoma
cavitate without associated infection.16
4. Tuberculosis manifesting radiologically as residual lesion mimicking residual tumour in patients with
chemotherapy and radiation therpay.  Sputum or bronchoalveolar lavage may demonstrate acid fast
bacilli.
5. Disssemination of mycobacteriosis causing miliary tuberculosis in an already immunocompromised
individual.  Such dissemination may follow chemotherapy and radiation therapy.
The true incidence of co existence of these
two may be higher and better laboratory
techniques particularly PCR based should be
helpful in detecting true incidence.
CONCLUSION
The present study highlights the co existence of
pulmonary tuberculosis and lung cancer. Study also
stress upon that there should be a high index of
suspicion in detecting tuberculosis in lung cancer
patients. The detection of this is all the more
important in a country like ours where prevalence
and incidence of tuberculosis is high. A new or
persistent lesion on chest x ray may be wrongly
diagnosed as disease progression indicating
treatment failure whereas, in fact this may be a
tubercular lesion  which can be effectively treated.
The true incidence may be still higher and newer
techniques PCR based and others may help in
knowing true incidence of co existence of lung
cancer and pulmonary tuberculosis.
Present report suggest that mycobacterium
tuberculosis may coexist with lung cancer at its
beginning more frequently than described.
Infections are one of the  leading cause of death in
patients with neoplastic diseases and mycobaterial
infection is one of  them. We feel sputum smear
evaluation for AFB at diagnosis and at frequent
intervals during the course of lung cancer at least
in endemic zones should be done.
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